Clinical Trial Update: Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular Edema [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating intravitreal ranibizumab for central retinal vein occlusion with macular edema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Vein Occlusion
• Macular Edema

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Vitreous -Retina- Macula Consultants of New York | Conditions: Retinal Vein Occlusion | Phase 1 | Status: COMPLETED